RET fusion in advanced non-small-cell lung cancer and response to cabozantinib: A case report

AbstractRationale:Lung cancer is a series of gene-driven disease. EGFR, ALK, and ROS1 are 3 major driver genes that play an important role in lung cancer development and precision management. Additionally, rare genetic alterations continue to be discovered and may become novel targets for therapy. T